Landec - Diversified Health and Wellness Solutions

Our mission is to create innovative products that support everyone’s unique health and wellness journey.

Home / 2015 / Landec to Present at the 27th Annual ROTH Conference on March 10, 2015

Landec to Present at the 27th Annual ROTH Conference on March 10, 2015

By

MENLO PARK, Calif., Feb. 26, 2015 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq:LNDC), a leading developer and marketer of innovative and proprietary products for healthy living applications in the food and biomedical markets, has been invited to present at the 27th Annual ROTH Conference. The conference is being held on March 8-11, 2015 at The Ritz Carlton in Dana Point, California.

Landec Chairman and CEO Gary Steele is scheduled to present on Tuesday, March 10 at 1:30 p.m. Pacific time, with one-on-one meetings held throughout the day. He will discuss Landec’s businesses, its market leadership and progress.

For additional information or to schedule a one-on-one meeting with Landec management, please contact your ROTH representative. For more about ROTH Capital Partners and the 27th Annual ROTH Conference, please visit www.roth.com.

About Landec Corporation

Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec’s subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec’s proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the Company, visit Landec’s website at www.landec.com.

CONTACT: At the Company:

         Gregory S. Skinner

         Vice President Finance and CFO

         (650) 261-3677



         Investor Relations:

         Matt Glover or Michael Koehler

         (949) 574-3860

         LNDC@liolios.com